Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Post-Neoadjuvant Gemcitabine and Cisplatin with Regional Hyperthermia for Patients with Triple-Negative Breast Cancer and Non-pCR after Neoadjuvant Chemotherapy: A Single-Institute Experience.
Stoetzer O, Di Gioia D, Issels RD, Abdel-Rahman S, Mansmann U, Lindner LH, Gluz O, Würstlein R, Braun M, Hamann M, Edler von Koch F, Harbeck N, Salat C. Stoetzer O, et al. Among authors: di gioia d. Breast Care (Basel). 2021 Apr;16(2):173-180. doi: 10.1159/000507473. Epub 2020 May 12. Breast Care (Basel). 2021. PMID: 34012372 Free PMC article.
Ifosfamide, Carboplatin, and Etoposide (ICE) in Combination with Regional Hyperthermia as Salvage Therapy in Patients with Locally Advanced Nonmetastatic and Metastatic Soft-Tissue Sarcoma.
Bücklein V, Limmroth C, Kampmann E, Schuebbe G, Issels R, Roeder F, Angele M, Dürr HR, Knösel T, Abdel-Rahman S, Di Gioia D, Lindner LH. Bücklein V, et al. Among authors: di gioia d. Sarcoma. 2020 Feb 27;2020:6901678. doi: 10.1155/2020/6901678. eCollection 2020. Sarcoma. 2020. PMID: 32189990 Free PMC article.
Expression Patterns of TOP2A and SIRT1 Are Predictive of Survival in Patients with High-Risk Soft Tissue Sarcomas Treated with a Neoadjuvant Anthracycline-Based Chemotherapy.
Berclaz LM, Altendorf-Hofmann A, Dürr HR, Klein A, Angele MK, Albertsmeier M, Schmidt-Hegemann NS, Di Gioia D, Knösel T, Lindner LH. Berclaz LM, et al. Among authors: di gioia d. Cancers (Basel). 2021 Sep 29;13(19):4877. doi: 10.3390/cancers13194877. Cancers (Basel). 2021. PMID: 34638362 Free PMC article.
Impact of postoperative baseline MRI on diagnostic confidence and performance in detecting local recurrence of soft-tissue sarcoma of the limb.
Goller SS, Reidler P, Rudolph J, Rückel J, Hesse N, Schmidt VF, Dürr HR, Klein A, Lindner LH, Di Gioia D, Kuhn I, Ricke J, Erber B. Goller SS, et al. Among authors: di gioia d. Skeletal Radiol. 2023 Oct;52(10):1987-1995. doi: 10.1007/s00256-023-04341-4. Epub 2023 May 2. Skeletal Radiol. 2023. PMID: 37129611 Free PMC article.
TIM-3 Qualifies as a Potential Immunotherapeutic Target in Specific Subsets of Patients with High-Risk Soft Tissue Sarcomas (HR-STS).
Berclaz LM, Altendorf-Hofmann A, Lindner LH, Burkhard-Meier A, Di Gioia D, Dürr HR, Klein A, Albertsmeier M, Schmidt-Hegemann NS, Klauschen F, Knösel T. Berclaz LM, et al. Among authors: di gioia d. Cancers (Basel). 2023 May 12;15(10):2735. doi: 10.3390/cancers15102735. Cancers (Basel). 2023. PMID: 37345075 Free PMC article.
Implementing precision oncology for sarcoma patients: the CCCLMUmolecular tumor board experience.
Berclaz LM, Burkhard-Meier A, Lange P, Di Gioia D, Schmidt M, Knösel T, Klauschen F, von Bergwelt-Baildon M, Heinemann V, Greif PA, Westphalen CB, Heinrich K, Lindner LH. Berclaz LM, et al. Among authors: di gioia d. J Cancer Res Clin Oncol. 2023 Nov;149(15):13973-13983. doi: 10.1007/s00432-023-05179-y. Epub 2023 Aug 5. J Cancer Res Clin Oncol. 2023. PMID: 37542550 Free PMC article.
120 results